rawfin.tv
Kynam Capital Reduces CG Oncology (CGON) Stake by $43.8 Million
Top StoriesstocksAI Generated

Kynam Capital Reduces CG Oncology (CGON) Stake by $43.8 Million

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Kynam Capital Management sold 1,059,375 shares of CG Oncology (CGON) in Q4, reducing its stake to 2.51% of its reportable assets under management. The divestment totals $43.8 million in shares.

CGONInstitutional SellingHedge FundsBiotechnologyFund Holdings

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks